A prospective, single-group cohort study of using Sufentanil sublingual tablets in complex outpatient plastic surgery procedures
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Sufentanil (Primary) ; Lorazepam
- Indications Postoperative pain
- Focus Therapeutic Use
Most Recent Events
- 09 Jan 2024 According to Talphera media release, AcelRx Pharmaceuticals changed its name to Talphera, Inc.
- 07 Nov 2022 New trial record
- 31 Oct 2022 Results presented in an AcelRx Pharmaceuticals Media Release.